M
Maija Haanpää
Researcher at University of Helsinki
Publications - 114
Citations - 13128
Maija Haanpää is an academic researcher from University of Helsinki. The author has contributed to research in topics: Neuropathic pain & Population. The author has an hindex of 41, co-authored 107 publications receiving 11374 citations. Previous affiliations of Maija Haanpää include Helsinki University Central Hospital.
Papers
More filters
Journal ArticleDOI
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B. Finnerup,Nadine Attal,Simon Haroutounian,Ewan D McNicol,Ralf Baron,Robert H. Dworkin,Ian Gilron,Maija Haanpää,Per Hansson,Per Hansson,Troels S. Jensen,Troels S. Jensen,Peter R. Kamerman,Karen Lund,Andrew Moore,Srinivasa N. Raja,Andrew S.C. Rice,Andrew S.C. Rice,Michael C. Rowbotham,Emily S. Sena,Emily S. Sena,Philip J. Siddall,Philip J. Siddall,Blair H. Smith,Mark S. Wallace +24 more
TL;DR: The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin.
Journal ArticleDOI
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Nadine Attal,Giorgio Cruccu,Ralf Baron,Maija Haanpää,Per Hansson,Troels S. Jensen,Turo Nurmikko +6 more
TL;DR: The second European Federation of Neurological Societies Task Force as discussed by the authors aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005, and identified studies using the Cochrane Database and Medline.
Journal ArticleDOI
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
Robert H. Dworkin,Alec B. O'Connor,Joseph Audette,Ralf Baron,Geoffrey K. Gourlay,Maija Haanpää,Joel L. Kent,Elliot J. Krane,Elliot J. Krane,Alyssa Lebel,Robert M. Levy,Sean Mackey,John M. Mayer,Christine Miaskowski,Srinivasa N. Raja,Andrew S.C. Rice,Kenneth E. Schmader,Brett R. Stacey,Steven P. Stanos,Rolf-Detlef Treede,Dennis C. Turk,Gary A. Walco,Christopher D. Wells +22 more
TL;DR: A review of the evidence-based guidelines for the pharmacological treatment of neuropathic pain can be found in this article, where botulinum toxin, high-concentration capsaicin patch, lacosamide, selective serotonin reuptake inhibitors, and combination therapies are presented.
Journal ArticleDOI
A new definition of neuropathic pain
Troels S. Jensen,Ralf Baron,Maija Haanpää,Eija Kalso,John D. Loeser,Andrew S.C. Rice,Rolf-Detlef Treede +6 more
TL;DR: A new definition of neuropathic pain is published which is defined as “pain caused by a lesion or disease of the somatosensory system” ( www.iasp-pain.org/resources/painDefinition).
Journal ArticleDOI
EFNS guidelines on pharmacological treatment of neuropathic pain
Nadine Attal,Giorgio Cruccu,Maija Haanpää,Per Hansson,Troels S. Jensen,Turo Nurmikko,Cristina Sampaio,Søren H. Sindrup,Philip J Wiffen +8 more
TL;DR: Evaluated trials provide level A evidence for the efficacy of tricyclic antidepressants, gabapentin, pregabalin and opioids, with a large number of class I trials, followed by topical lidocaine and the newer antidepressants venlafaxine and duloxetine.